Blood pressure variability: a review

Вариабельность артериального давления: обзор
Spoorthy Kulkarni, Gianfranco Parati, Sripal Bangalore, Grzegorz Bilo, Bum Joon Kim, Kazuomi Kario, Franz H. Messerli, George S. Stergiou, Ji‐Guang Wang, William Whiteley, Ian B. Wilkinson, Peter S. Sever
2025-03-10

QRISKblood pressure variabilitycardiovascular eventslong-acting dihydropyridinesthiazide diuretics
Blood pressure variability (BPV) predicts cardiovascular events independent of mean blood pressure. BPV is defined as short-term (24-h), medium or long- term (weeks, months or years). Standard deviation, coefficient of variation and variation independent of the mean have been used to quantify BPV. High BPV is associated with increasing age, diabetes, smoking and vascular disease and is a consequence of premature ageing of the vasculature. Long-term BPV has been incorporated into cardiovascular risk models (QRISK) and elevated BPV confers an increased risk of cardiovascular outcomes even in subjects with controlled blood pressure. Long-acting dihydropyridine calcium channel blockers and thiazide diuretics are the only drugs that reduce BPV and for the former explains their beneficial effects on cardiovascular outcomes. We believe that BPV should be incorporated into blood pressure management guidelines and based on current evidence, long-acting dihydropyridines should be preferred drugs in subjects with elevated BPV.
1
Blood pressure variability is categorized as short-term over 24 hours, medium-term over weeks, and long-term over months or years.
2
Blood pressure variability predicts cardiovascular events independently of mean blood pressure.
3
Higher blood pressure variability is associated with older age, diabetes, smoking, vascular disease, and premature vascular ageing.
4
Long-acting dihydropyridine calcium channel blockers and thiazide diuretics are identified as the only drug classes that reduce blood pressure variability; long-acting dihydropyridines are recommended preferentially for patients with elevated variability.
5
Long-term blood pressure variability increases cardiovascular risk even when blood pressure is controlled and is incorporated into the QRISK model.
6
Standard deviation, coefficient of variation, and variation independent of the mean are used to quantify blood pressure variability.

Blood pressure variability in human subjects

The temporal patterns, quantification, determinants, cardiovascular risk significance, and pharmacological reduction of blood pressure variability

Publication Details
Publication Date
2025-03-10
Journal
Publisher
ISSN
Cited by
45
Access Type
Author Information
Authors
Spoorthy Kulkarni
Gianfranco Parati
Sripal Bangalore
Grzegorz Bilo
Bum Joon Kim
Kazuomi Kario
Franz H. Messerli
George S. Stergiou
Ji‐Guang Wang
William Whiteley
Ian B. Wilkinson
Peter S. Sever
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%